Application Notes & Case Studies

  1. Commercializing Rare Disease Treatment With Near Real-Time Alerts 5/16/2025

    How did Quest help a leading pharmaceutical company overcome the data latency challenges associated with traditional EHR when recruiting eligible patients for a rare blood disorder drug?

  2. Understanding Real-World Patient Characterization And Safety Outcomes Of DEXTENZA 5/8/2025

    In this study, we can derive confirmation of DEXTENZA’s favorable safety profile across a broader surgical spectrum.

  3. Refining Patient Segmentation And Reversing A Medicare Ruling For OMNI 5/8/2025

    Leveraging a partnership with Verana, Sight Sciences facilitated the reversal of a Limited Coverage Determination that threatened the utilization of one of their surgical system in glaucoma treatments.

  4. Solutions To The Challenges Of Oncology Trials 5/6/2025

    This significant Phase III trial, one of the largest global studies in head and neck cancer, faced considerable challenges including enrollment delays and an intricate study design.

  5. Optimizing Kitting For Cell Therapy Trials In Pediatric Oncology 5/2/2025

    Precision for Medicine’s Kitting team played a crucial role in overcoming this challenges of a Phase I multicenter pediatric cell therapy trial targeting relapsed or refractory solid tumors.

  6. EHR-To-EDC Success In A Complex, Adaptive Platform Trial 4/17/2025

    I-SPY 2, one of the longest-running adaptive platform trials in oncology, is revolutionizing breast cancer research through a dynamic, data-driven approach to evaluating novel therapies.

  7. Unlocking Recruitment Potential In Trial-Naïve Sites 4/17/2025

    Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.

  8. Delivering Specialist Neurology Support 4/17/2025

    Explore a strategic approach to a Parkinson’s disease trial that leveraged a global infrastructure and multilingual workforce to provide seamless operational and clinical support.

  9. Enhance Access And Improve Retention In Rare Disease Trials With HTS 4/17/2025

    Home Trial Support (HTS) provides a solution to improving participant recruitment and retention during musculoskeletal studies.

  10. Accelerating Early Phase Oncology Study Development 4/17/2025

    Explore a close collaboration to co-develop a comprehensive, adaptive protocol designed to support key decisions across multiple trial phases for an innovative cancer therapy.